We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.69B
AUM Growth
-$77.2M
Cap. Flow
-$122M
Cap. Flow %
-7.21%
Top 10 Hldgs %
19.67%
Holding
509
New
80
Increased
151
Reduced
135
Closed
101

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$94.7M
2
CGNX icon
Cognex
CGNX
+$22.8M
3
BIIB icon
Biogen
BIIB
+$9.81M
4
TRU icon
TransUnion
TRU
+$9.41M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$9.33M

Sector Composition

Rank Sector Weight
1 Healthcare 31.24%
2 Technology 24.62%
3 Consumer Discretionary 13.94%
4 Financials 6.61%
5 Industrials 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONDK
351
DELISTED
On Deck Capital, Inc.
ONDK
$280K 0.02%
67,400
BNED icon
352
Barnes & Noble Education
BNED
$412M
$277K 0.02%
825
+245
+42% +$94.1K
OCSL icon
353
Oaktree Specialty Lending
OCSL
$1.03B
$267K 0.02%
16,433
-567
-3% -$9.17K
VRTV
354
DELISTED
VERITIV CORPORATION
VRTV
$252K 0.01%
13,000
+3,900
+43% +$89.9K
ELGX
355
DELISTED
Endologix Inc
ELGX
$242K 0.01%
33,400
+19,440
+139% +$133K
GNMK
356
DELISTED
GenMark Diagnostics, Inc
GNMK
$234K 0.01%
36,000
DNLI icon
357
Denali Therapeutics
DNLI
$3.67B
$233K 0.01%
+11,220
New +$251K
BFIN
358
DELISTED
BankFinancial
BFIN
$231K 0.01%
16,500
ARD
359
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$231K 0.01%
13,200
-2,100
-14% -$30.6K
ARCE
360
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$229K 0.01%
+5,220
New +$194K
VSI
361
DELISTED
Vitamin Shoppe Inc.
VSI
$213K 0.01%
54,100
-28
-0.1% -$145
ERII icon
362
Energy Recovery
ERII
$434M
$209K 0.01%
20,100
-4,300
-18% -$42.3K
JE
363
DELISTED
Just Energy Group Inc
JE
$208K 0.01%
1,462
-911
-38% -$110K
GYRE icon
364
Gyre Therapeutics
GYRE
$662M
$206K 0.01%
+3,720
New +$232K
BKCC
365
DELISTED
BlackRock Capital Investment Corporation
BKCC
$200K 0.01%
33,176
+76
+0.2% +$466
PNNT
366
Pennant Park Investment Corp
PNNT
$215M
$198K 0.01%
31,400
-48
-0.2% -$323
CAMT icon
367
Camtek
CAMT
$6.9B
$194K 0.01%
+22,900
New +$211K
HLIT icon
368
Harmonic Inc
HLIT
$1.21B
$193K 0.01%
34,813
+42
+0.1% +$233
AMRC icon
369
Ameresco
AMRC
$1.15B
$189K 0.01%
12,842
+1,190
+10% +$18.2K
SNDA icon
370
Sonida Senior Living
SNDA
$1.97B
$189K 0.01%
2,500
+646
+35% +$40.7K
SYRS
371
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$187K 0.01%
+2,020
New +$141K
AOSL icon
372
Alpha and Omega Semiconductor
AOSL
$923M
$183K 0.01%
19,578
PTGX icon
373
Protagonist Therapeutics
PTGX
$8.75B
$182K 0.01%
+15,011
New +$166K
NEXA icon
374
Nexa Resources
NEXA
$1.7B
$181K 0.01%
18,856
+3,856
+26% +$41.5K
UCFC
375
DELISTED
United Community Financial Corp
UCFC
$180K 0.01%
18,815
-4,300
-19% -$40.1K

Similar funds

PDT Partners's Q2 2019 Portfolio in Review

As of Q2 2019, PDT Partners held 509 positions worth $1.69B, down 4.4% from $1.77B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

PDT Partners withdrew a net $122M in Q2 2019, closing 101 positions and reducing 135 holdings. Its most notable exit was Amazon, an estimated $30.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in AbbVie worth $87.6M.

  • PDT Partners's largest Q2 2019 buy was AbbVie: 1,205,251 shares worth $87.6M.
  • PDT Partners added most to Block Inc in Q2 2019, an estimated $8.46M increase.
  • PDT Partners's biggest Q2 2019 reduction was American International, cutting an estimated $7.38M.
  • PDT Partners fully exited Amazon in Q2 2019, selling an estimated $30.6M.
  • PDT Partners's ten largest holdings make up 20% of its $1.69B portfolio in Q2 2019.
  • PDT Partners opened 80 new positions and closed 101 in Q2 2019.
  • PDT Partners's portfolio value fell 4.4% quarter-over-quarter to $1.69B.

Based on PDT Partners's 13F filing for Q2 2019, filed 14 Aug 2019.